13
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Inhibition of human fetal brain acetylcholinesterase: Marker effect of neurotoxicity

, , , &
Pages 283-290 | Received 04 Jun 1990, Accepted 30 Jan 1991, Published online: 15 Oct 2009
 

Abstract

Human fetal brains were obtained after medical termination of pregnancy at 8–10 wk from informed patients. A definite regionalization of AChE was found in the brain of the fetus, with cerebellum recording the highest and cerebral hemisphere the lowest activity. Optimum conditions for the cerebellar AChE activity were determined with respect to molarity of the buffer, pH, temperature, and concentrations of substrate (acetylthiocholine iodide), activators (NaCI, MgCI2), and thiol indicator (dithiobisnitro‐benzoic acid). In vitro inhibition of cerebellar AChE with two commercial pesticides, Metacid‐50 (O,O‐dimethyl p‐nitrophenyl phosphorothioate) and carbaryl (N‐methyl naphthyl‐1‐carbamate), were compared with pure anticholinesterase agents, diisopropylfluorophosphate (DFP) and physostigmine (eserine). In general, organophosphates are more neurotoxic than carbamate compounds, as evidenced by higher degree of AChE inhibition by DFP and Metacid‐50 as compared to eserine and carbaryl. Assays were also done with psychotropic drugs by employing the procedure of in vitro AChE inhibition kinetics, and it was found that psychotropic drugs are less potent than organophosphate and carbamate compounds. Results indicate that pure and commercial organophosphates and carbamates and psychotropic drugs are all able to significantly alter the AChE activity. Thus exposure of the mother to these environmental toxicants may adversely affect the fetal neural functions.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.